Bloomage Biotech(SH:688363) Zheng Quan Zhi Xing·2025-06-11 13:08Core Viewpoint - The announcement details the completion of the board of directors' re-election and the appointment of senior management personnel at Huaxi Biological Technology Co., Ltd. The third board of directors has been elected for a term of three years, and key management positions have been filled. Group 1: Board of Directors Election - The third board of directors was elected during the annual general meeting on June 11, 2025, with Zhao Yan, Guo Jiajun, Li Yizheng, Wang Hui, Yu Jing, and Chen Yuxin as non-independent directors, and Yao Yang, Chen Daliang, and Xu Wenming as independent directors [1][2] - Zhao Yan was elected as the chairman of the third board of directors, with a term starting from the approval date until the end of the board's term [2] - The board established several specialized committees, including the Strategy Committee, Audit Committee, Nomination Committee, Compensation and Assessment Committee, ESG Committee, and Risk Management Committee, with independent directors holding a majority in key committees [2][3] Group 2: Senior Management Appointments - Zhao Yan was appointed as the General Manager, with Guo Jiajun, Li Yizheng, Wang Hui, and Xiang Maogong appointed as Deputy General Managers. Li Yizheng also serves as the Board Secretary, and Wang Hui as the Chief Financial Officer [4] - The appointments of senior management personnel were approved by the Nomination Committee, and their qualifications were reviewed accordingly [4] - Li Yizheng holds the qualification certificate for the Board Secretary of the Shanghai Stock Exchange's Sci-Tech Innovation Board, confirming his eligibility for the position [4] Group 3: Management Profiles - Zhao Yan, born in July 1966, holds a bachelor's degree in biology and an MBA from Fordham University. She has held various leadership roles within the company since 2000 [5] - Guo Jiajun, born in September 1975, has an MBA from Fordham University and has served in various managerial positions within the company since 2002 [6] - Li Yizheng, born in September 1984, holds a master's degree in investment studies and has extensive experience in investment banking prior to joining the company in 2021 [7] - Wang Hui, born in September 1983, is a CPA and has held various financial management roles before joining the company in September 2023 [8] - Xiang Maogong, born in February 1984, has a background in microbiology and has worked in various roles in the pharmaceutical industry [8]